Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Eye-Tracking Screening for Autism in 9-Month-Old Infants

Tests an eye-tracking device that measures social looking to screen 9-month-old infants for autism.

Plain-language title generated from the registry record
Registry title: Screening for Autism in 9-Month-Olds by Measuring Social Visual Engagement

Key facts

Where
Atlanta, United StatesSee the 2 sites

Where in United States

  • Children's Healthcare of AtlantaAtlanta, United StatesTaking people
  • Emory UniversityAtlanta, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Emory University
Trial code
NCT05916430
Record updated
4 June 2026
Original description
The goal of this project is to measure the clinical utility of an objective and quantitative eye-tracking assay collected on a standalone, mobile investigational device to accurately screen 9-month-old infants for autism spectrum disorder and other actionable delays.Read full original descriptionShow less

Community-viable Screening for Autism Spectrum Disorder (ASD) in 9-month-old Infants Using Quantitative Eye-tracking Assays of Social Visual Engagement

The goal of this project is to measure the clinical utility of an objective and quantitative eye-tracking assay collected on a standalone, mobile investigational device to accurately screen 9-month-old infants for autism spectrum disorder and other actionable delays.

Inclusion: Infants between the chronological ages of 8-10 months; Infants must be generally healthy with no acute illnesses likely to prevent successful or valid data collection (e.g., current vomiting, high fever, conjunctivitis affecting vision); Participants' parents/caregivers must be able to understand and voluntarily provide written informed consent.

Exclusion: Children will be excluded if they have signs of acute illness likely to prevent successful or valid data collection (e.g., conjunctivitis affecting vision, current vomiting, or high fever).

ClinicalTrials.gov NCT05916430